CHYHY:OTC-Chr. Hansen Holding A/S (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 23.83

Change

0.00 (0.00)%

Market Cap

USD 12.56B

Volume

0.02M

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Chr. Hansen Holding A/S, a bioscience company, develops and sells natural ingredient solutions for food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia-Pacific. It operates through Food Cultures & Enzymes and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. Chr. The company was founded in 1874 and is headquartered in Hørsholm, Denmark.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-26 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD40.44B 95.63 0.36
GVDBF Givaudan SA

N/A

USD36.33B 46.00 32.14
GVDNY Givaudan SA

N/A

USD36.30B 46.49 32.14
SKFOF Sika AG

N/A

USD35.46B 52.94 30.31
SXYAY Sika AG

N/A

USD35.07B 53.52 30.82
KDSKF Koninklijke DSM N.V

N/A

USD27.96B 40.76 26.74
RDSMY Koninklijke DSM N.V

N/A

USD27.51B 40.69 26.74
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD20.86B 42.35 38.99
AKZOF Akzo Nobel N.V

N/A

USD19.74B 30.53 16.55
AKZOY Akzo Nobel N.V

N/A

USD19.62B 31.18 16.55

ETFs Containing CHYHY

Symbol Name Weight Mer Price(Change) Market Cap
RFDI First Trust RiverFront Dy.. 0.00 % 0.83 %

N/A

USD0.13B
ORG The Organics ETF 0.00 % 0.35 %

N/A

USD6.05M
EXSD:F iShares STOXX Europe Mid .. 0.00 % 0.21 %

-0.11 (-0.23%)

USD0.29B
EXSD:XETRA iShares STOXX Europe Mid .. 0.00 % 0.21 %

+0.06 (+0.12%)

USD0.28B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.27% 58% F 66% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.27% 58% F 66% D
Trailing 12 Months  
Capital Gain 26.96% 60% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.96% 59% F 68% D+
Trailing 5 Years  
Capital Gain 54.34% 65% D 69% D+
Dividend Return 8.63% 53% F 33% F
Total Return 62.97% 66% D 69% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.65% N/A N/A 63% D
Dividend Return 1.48% N/A N/A 48% F
Total Return 13.14% N/A N/A 63% D
Risk Return Profile  
Volatility (Standard Deviation) 24.95% N/A N/A 64% D
Risk Adjusted Return 52.67% N/A N/A 86% B
Market Capitalization 12.56B 86% B 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 45.89 27% F 16% F
Price/Book Ratio 12.80 7% F 12% F
Price / Cash Flow Ratio 34.44 8% F 5% F
EV/EBITDA 38.44 7% F 9% F
Management Effectiveness  
Return on Equity 27.41% 96% A 94% A
Return on Invested Capital 21.41% 88% B+ 83% B
Return on Assets 8.40% 88% B+ 93% A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.21 83% B 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector